Cladribine April 12, 2017 Cladribine Trade Name Leustatin Injection Orphan Indication Non-Hodgkin's lymphoma USA Market Approval USA USA Designation Date 1993-04-19 00:00:00 Sponsor Janssen Research & Development, LLC;920 US Highway 202;Raritan, New Jersey, 08869
